hrcak mascot   Srce   HID

Libri Oncologici : Croatian Journal of Oncology, Vol. 42 No. 1-3, 2014.

Pregledni rad

Systemic therapy of early breast cancer

Robert Šeparović   ORCID icon orcid.org/0000-0002-4002-2699 ; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Tajana Silovski ; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Robert Zorica ; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Mirjana Pavlović ; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Ljubica Vazdar ; Department of Medical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia
Vesna Pavlica ; Hospital Pharmacy, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, Croatia

Puni tekst: engleski, pdf (177 KB) str. 41-50 preuzimanja: 81* citiraj
APA 6th Edition
Šeparović, R., Silovski, T., Zorica, R., Pavlović, M., Vazdar, Lj. i Pavlica, V. (2014). Systemic therapy of early breast cancer. Libri Oncologici, 42 (1-3), 41-50. Preuzeto s https://hrcak.srce.hr/199077
MLA 8th Edition
Šeparović, Robert, et al. "Systemic therapy of early breast cancer." Libri Oncologici, vol. 42, br. 1-3, 2014, str. 41-50. https://hrcak.srce.hr/199077. Citirano 17.01.2021.
Chicago 17th Edition
Šeparović, Robert, Tajana Silovski, Robert Zorica, Mirjana Pavlović, Ljubica Vazdar i Vesna Pavlica. "Systemic therapy of early breast cancer." Libri Oncologici 42, br. 1-3 (2014): 41-50. https://hrcak.srce.hr/199077
Harvard
Šeparović, R., et al. (2014). 'Systemic therapy of early breast cancer', Libri Oncologici, 42(1-3), str. 41-50. Preuzeto s: https://hrcak.srce.hr/199077 (Datum pristupa: 17.01.2021.)
Vancouver
Šeparović R, Silovski T, Zorica R, Pavlović M, Vazdar Lj, Pavlica V. Systemic therapy of early breast cancer. Libri Oncologici [Internet]. 2014 [pristupljeno 17.01.2021.];42(1-3):41-50. Dostupno na: https://hrcak.srce.hr/199077
IEEE
R. Šeparović, T. Silovski, R. Zorica, M. Pavlović, Lj. Vazdar i V. Pavlica, "Systemic therapy of early breast cancer", Libri Oncologici, vol.42, br. 1-3, str. 41-50, 2014. [Online]. Dostupno na: https://hrcak.srce.hr/199077. [Citirano: 17.01.2021.]

Sažetak
Breast cancer is the most common cancer in women. Early breast cancer is potentially curable disease. Systemic adjuvant therapy is created to treat micrometastatic disease or destroy breast cancer cells that have spread from the breast and regional lymph nodes, but have not yet formed visible distant metastases. Systemic adjuvant therapy is based on chemotherapy
with or without targeted therapy, and endocrine therapy, sometimes in combination with adjuvant irradiation, usually is conducted after surgery. The aim of adjuvant therapy is to decrease recurrence rate and extension of overall survival

Ključne riječi
breast cancer; micrometastasis; adjuvant chemotherapy; biological therapy; survival rate

Hrčak ID: 199077

URI
https://hrcak.srce.hr/199077

[hrvatski]

Posjeta: 520 *